Humanized antibodies to Abeta(20-42) globulomer and uses thereof

Details for Australian Patent Application No. 2008260062 (hide)

Owner Abbott Laboratories Abbott GmbH & Co. KG

Inventors Ebert, Ulrich; Labkovsky, Boris; Hinton, Paul R.; Barghorn, Stefan; Keller, Patrick; Hillen, Heinz; Striebinger, Andreas R.; Juan, Veronica M.

Agent Spruson & Ferguson

Pub. Number AU-A-2008260062

PCT Pub. Number WO2008/150949

Priority 60/990,359 27.11.07 US; 60/940,932 30.05.07 US

Filing date 30 May 2008

Wipo publication date 11 December 2008

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/150949 Priority application(s): WO2008/150949

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260070-Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles

2008260061-Methods for the commercial production of transgenic plants